Purchase Order 75N91023P00665
Award Date
8/1/23
Potential Completion Date
7/31/24
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order valued at eleven thousand nine hundred eighteen dollars and thirty-four cents ($11,918.34) to Illumina, Inc. to provide a NextSeq 2000 Silver Support Plan for the period of November 2, 2023 through January 31, 2024. The support plan is for a NextSeq 2000 sequencer located at the National Cancer Institute in Bethesda, Maryland and will maintain...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,646 purchase order to Illumina, Inc. for service agreement on a NovaSeq 6000 sequencer. The firm fixed price contract runs from December 1, 2023 through January 17, 2024 and will be performed in Rockville, Maryland. This purchase order provides sequencing services utilizing Illumina's NovaSeq 6000 platform to support the National Cancer Institute's cancer research efforts. No major...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $23,014 purchase order to Illumina, Inc. for maintenance of a MISEQ instrument with serial number MO8636. The one-year firm fixed price contract runs from December 13, 2023 through December 12, 2024 and will provide maintenance services for the sequencing platform to support research at the agency's Bethesda, Maryland facility. Illumina will serve as the prime contractor on this small purchase...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
This federal contract award is for a MiSeq Silver Support Plan from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $16,198.00, is with the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract is for a one-year period from August 1, 2024 to July 31, 2025 and is structured as a firm fixed price purchase order. The contract has no set-aside designation. Illumina...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract to Illumina, Inc. for maintenance services on the agency's Illumina MiSeq and NextSeq gene sequencing instruments. The contract has a potential value of $240,423.72 and covers a 12-month base period from May 13, 2019 to May 12, 2020, with four 12-month option periods. The contract provides for preventive maintenance inspections, replacement parts,...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order valued at ninety-nine thousand seven hundred fifty-five dollars to Illumina, Inc. to provide support services for a MiSeq Silver support plan and a NextSeq 500 Bronze support plan. The support plans are for specific Illumina sequencing instruments located in Potomac, Maryland and are required to maintain instrument subsystems and...
This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $130,847 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The purpose is to procure preventive maintenance services for a government-owned Illumina NovaSeq 6000 Sequencing System located at the National Cancer Institute in Bethesda, Maryland. The Laboratory of Pathology requires these services to maintain optimal instrument operation, generate comparable...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The potential value of the contract is $120,201.95 and the period of performance runs through August 29, 2023. The original solicitation indicated that the government intended to award this sole source contract to Illumina for support plans covering their MiSeq, NovaSeq 6000,...